Endometrial Cancer Is Rising: Warning Signs Women Shouldn’t Ignore
15:18
Baptist Health Cancer Care
Host: Sandra Peebles, award-winning journalist
Published: September 1, 2026
Host: Sandra Peebles, award-winning journalist
Published: September 1, 2026
Endometrial cancer cases are rising — and abnormal bleeding is the warning sign women should never ignore. Who is most at risk, why are more women being diagnosed, and what symptoms should prompt a call to your doctor? In this episode of Baptist Health Talk, host Sandra Peebles speaks with Dr. John Diaz, gynecological oncologist at the Herbert Wertheim Cancer Institute, about what women need to know about endometrial cancer, from early warning signs and risk factors to diagnosis, treatment and fertility-preserving options.
- Why endometrial cancer cases are increasing in the U.S. and around the world
- How obesity and prolonged estrogen exposure can raise risk
- The abnormal bleeding patterns women should report — including after menopause
- Other warning signs such as pelvic pain, bloating and abnormal discharge
- Why endometrial cancer can also affect younger women
- How doctors diagnose endometrial cancer and why there is no routine screening test
- Treatment options for early and advanced disease, including immunotherapy
- When fertility-sparing treatment may be possible
- How family history and Lynch syndrome can affect risk
Host: Sandra Peebles, award-winning journalist
Guest: John P. Diaz, M.D., chief of Gynecologic Oncology, Herbert Wertheim Cancer Institute, and Chair, Obstetrics & Gynecology at Florida International University
Featured Provider
John Paul Diaz, MD
John P. Diaz, M.D., FACOG, FACS, is a board-certified gynecologic oncologist at Baptist Health Herbert Wertheim Cancer Institute. He holds multiple leadership roles, including chief of gynecologic oncology at Baptist Health and director of robotic surgery and lead physician for clinical trials in gynecologic oncology at Herbert Wertheim Cancer Institute. He also serves as chair and associate professor of the Department of Obstetrics and Gynecology at Florida International University Herbert Wertheim College of Medicine.
Dr. Diaz provides comprehensive and compassionate gynecologic cancer care for women with endometrial, ovarian, cervical, vaginal or vulvar cancer. He has extensive training and experience in robotic and minimally invasive surgery, which results in shorter hospital stays and faster recovery times for patients.
A surgical innovator, Dr. Diaz has helped pioneer novel procedures such as fertility-sparing radical trachelectomy for early-stage cervical cancer and sentinel lymph node mapping in gynecologic malignancies. He also performed Florida’s first uterine transposition procedure for a patient with gynecologic cancer, preserving reproductive potential in a groundbreaking approach.
Under the direction of Dr. Diaz, Herbert Wertheim Cancer Institute’s gynecologic oncology research and clinical trials program offers innovative treatments and advanced technologies to women in South Florida. His research interests include new surgical methods for ovarian cancer and innovative cancer therapies like hyperthermic intraperitoneal chemotherapy and immunotherapy. He was awarded a $1.7 million research grant to investigate novel therapeutics for the treatment of gynecologic cancers.
Dr. Diaz has authored numerous peer-reviewed publications and presented his research at scientific symposiums. He serves as a reviewer for Gynecologic Oncology, BioMed Cancer, International Journal of Gynecologic Oncology and the Annals of Surgical Oncology. He also holds several leadership and committee positions within such professional organizations as the Society of Gynecologic Oncology and the American College of Obstetrics and Gynecology.
Dr. Diaz earned his medical degree at the University of Miami Miller School of Medicine and was inducted into the Iron Arrow Honor Society, the university’s highest honor. He completed a residency in obstetrics and gynecology at Jackson Memorial Hospital, University of Miami Miller School of Medicine. He also completed a fellowship in gynecologic oncology at Memorial Sloan Kettering Cancer Center in New York, N.Y., where he was awarded the Department of Surgery’s Chairman’s Award for Excellence in Clinical Research.
Dr. Diaz is dedicated to advancing women’s health, cancer care, surgical innovation and academic leadership on both a regional and national level. He is fluent in English and Spanish.
Compassionate, Expert Cancer Care at Baptist Health
Related Stories
View All Articles
From PCOS to PMOS: Why Redefinition of a Common Condition Matters for Women
August 18, 2026
9 min. read
The PCOS Name Change: Why PMOS Better Reflects the Whole-Body Condition
July 31, 2026
25:54